CDC Panel Removes Universal Hepatitis B Recommendation
A CDC advisory panel voted on Thursday to remove the longstanding universal recommendation to give U.S. infants a hepatitis B vaccine dose at birth, recommending shared clinical decision-making for infants of mothers who test negative. The committee preserved birth-dose guidance for infants of hepatitis B–positive mothers and endorsed post-vaccination antibody testing to determine need for additional doses. Public-health experts warned the change could reduce early vaccination coverage.
Key Points
- 1Removes universal birth-dose recommendation for hepatitis B for infants of mothers testing negative
- 2Highlights concerns about prenatal testing gaps, false negatives, and potential missed infections at birth
- 3Implies clinicians must use shared decision-making and consider antibody testing to guide additional doses
Scoring Rationale
High policy significance and clinical implications, but limited to public-health domain outside core AI/ML relevance.
Sources
Public references used for this report.
Practice interview problems based on real data
1,625 SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problems
